Encompass Health (NYSE:EHC) Issues Earnings Results

Encompass Health (NYSE:EHCGet Rating) issued its quarterly earnings data on Wednesday. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04, MarketWatch Earnings reports. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.32 billion. Encompass Health had a return on equity of 19.20% and a net margin of 8.05%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.05 EPS. Encompass Health updated its FY22 guidance to $3.83-4.19 EPS.

Shares of EHC opened at $65.23 on Thursday. Encompass Health has a 1 year low of $56.31 and a 1 year high of $89.11. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.23 and a quick ratio of 1.23. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 15.87, a price-to-earnings-growth ratio of 2.49 and a beta of 0.99. The business has a 50-day moving average of $69.22 and a 200-day moving average of $65.93.

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 18th. Stockholders of record on Friday, April 1st were given a dividend of $0.28 per share. The ex-dividend date of this dividend was Thursday, March 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.72%. Encompass Health’s dividend payout ratio (DPR) is 27.25%.

Several research firms have recently issued reports on EHC. Zacks Investment Research raised Encompass Health from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a report on Monday, April 11th. Truist Financial upped their price objective on Encompass Health from $78.00 to $85.00 in a research report on Thursday, April 7th. TheStreet upgraded Encompass Health from a “c+” rating to a “b-” rating in a research report on Tuesday, March 15th. Raymond James dropped their target price on Encompass Health from $90.00 to $80.00 and set a “strong-buy” rating for the company in a research report on Monday, February 7th. Finally, Credit Suisse Group dropped their target price on Encompass Health from $84.00 to $77.00 in a research report on Thursday, February 3rd. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $83.89.

Institutional investors and hedge funds have recently modified their holdings of the company. EverSource Wealth Advisors LLC bought a new position in shares of Encompass Health during the fourth quarter worth about $78,000. Virtu Financial LLC bought a new position in shares of Encompass Health during the fourth quarter worth about $297,000. MML Investors Services LLC raised its position in shares of Encompass Health by 7.4% during the fourth quarter. MML Investors Services LLC now owns 7,128 shares of the company’s stock worth $465,000 after acquiring an additional 490 shares during the last quarter. LPL Financial LLC raised its position in shares of Encompass Health by 11.1% during the fourth quarter. LPL Financial LLC now owns 18,077 shares of the company’s stock worth $1,180,000 after acquiring an additional 1,806 shares during the last quarter. Finally, Metropolitan Life Insurance Co NY raised its position in shares of Encompass Health by 2.2% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 20,368 shares of the company’s stock worth $1,329,000 after acquiring an additional 431 shares during the last quarter. Institutional investors own 92.35% of the company’s stock.

Encompass Health Company Profile (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also

Earnings History for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.